1. Home
  2. NKTX vs TAVI Comparison

NKTX vs TAVI Comparison

Compare NKTX & TAVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTX
  • TAVI
  • Stock Information
  • Founded
  • NKTX 2015
  • TAVI 2024
  • Country
  • NKTX United States
  • TAVI United Kingdom
  • Employees
  • NKTX N/A
  • TAVI N/A
  • Industry
  • NKTX Biotechnology: Pharmaceutical Preparations
  • TAVI
  • Sector
  • NKTX Health Care
  • TAVI
  • Exchange
  • NKTX Nasdaq
  • TAVI Nasdaq
  • Market Cap
  • NKTX 170.8M
  • TAVI 160.0M
  • IPO Year
  • NKTX 2020
  • TAVI 2024
  • Fundamental
  • Price
  • NKTX $1.71
  • TAVI $10.08
  • Analyst Decision
  • NKTX Strong Buy
  • TAVI
  • Analyst Count
  • NKTX 6
  • TAVI 0
  • Target Price
  • NKTX $15.00
  • TAVI N/A
  • AVG Volume (30 Days)
  • NKTX 2.5M
  • TAVI 9.6K
  • Earning Date
  • NKTX 05-08-2025
  • TAVI 01-01-0001
  • Dividend Yield
  • NKTX N/A
  • TAVI N/A
  • EPS Growth
  • NKTX N/A
  • TAVI N/A
  • EPS
  • NKTX N/A
  • TAVI 0.01
  • Revenue
  • NKTX N/A
  • TAVI N/A
  • Revenue This Year
  • NKTX N/A
  • TAVI N/A
  • Revenue Next Year
  • NKTX N/A
  • TAVI N/A
  • P/E Ratio
  • NKTX N/A
  • TAVI $2,014.18
  • Revenue Growth
  • NKTX N/A
  • TAVI N/A
  • 52 Week Low
  • NKTX $1.31
  • TAVI $9.89
  • 52 Week High
  • NKTX $8.53
  • TAVI $10.35
  • Technical
  • Relative Strength Index (RSI)
  • NKTX 50.34
  • TAVI N/A
  • Support Level
  • NKTX $1.42
  • TAVI N/A
  • Resistance Level
  • NKTX $1.99
  • TAVI N/A
  • Average True Range (ATR)
  • NKTX 0.19
  • TAVI 0.00
  • MACD
  • NKTX 0.01
  • TAVI 0.00
  • Stochastic Oscillator
  • NKTX 31.52
  • TAVI 0.00

About NKTX Nkarta Inc.

Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer and autoimmune diseases. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer. The Company's operations are based in South San Francisco, California.

About TAVI Tavia Acquisition Corp. Ordinary Shares

Tavia Acquisition Corp is a blank check company.

Share on Social Networks: